NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/06/2023
Back to search
Official data from USPTO
GENESCAPE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
06/06/2023
Trademark type
Word
Nice classes
42
Filing date
04/21/2022
Registration date
06/06/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/06/2023
Last transaction
06/06/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/27/2020
First use in commerce
06/06/2021
Drawing code
4
Owner type
16
Owner location
Miami, FL, US
Examiner
NGUYEN, CINDY EVANS
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Genetic Networks, LLC
Representatives
MICHAEL J. KELLER KELLER LIFE SCIENCE LAW, PA
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Drug discovery services; scientific and technological servicesnamely scientific research and analysis in the field of target and drug optimization; scientific research screening of pharmaceuticals and biologics for therapeutic use including small moleculesproteinsRNA and DNA; scientific research screening using an entire genomes response to an administered compound or compounds; scientific research screening to find responses to therapeutic compounds by gene variants in a patient population; scientific research screening to find adverse events to therapeutic compounds and functional gene cluster mapping of interacting genes of an entire genomic response to administered compound; scientific research for medical purposes for identification of new clinical indications for known compounds; scientific research for medical purposes for comprehensive disease space mapping to understand how a compound fits into a disease space; and scientific research in the nature of comprehensive analysis of competitive drugs and derivatives thereof from a functional genome response to find new drug targets
Publications
History of USPTO decisions and trademark events.
13 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/21/2023
PUBO
PUBLISHED FOR OPPOSITION
03/21/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/16/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
02/15/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/15/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
02/15/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/15/2023
DOCK
ASSIGNED TO EXAMINER
02/08/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/27/2022
NWAP
NEW APPLICATION ENTERED
04/25/2022
Continuous trademark protection
Get notified about every new filing that threatens GENESCAPE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.